Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/42/79/86/427986d7-43ae-db57-604e-2cb279213fac/mza_7407224300728278017.jpg/600x600bb.jpg
Dangerous Ideas In Drug Development
NSW Early Phase Clinical Trials Alliance (NECTA)
20 episodes
4 weeks ago
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
Show more...
Medicine
Health & Fitness
RSS
All content for Dangerous Ideas In Drug Development is the property of NSW Early Phase Clinical Trials Alliance (NECTA) and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/38424943/38424943-1689065278050-30e218f9af614.jpg
Precision AI with Artera
Dangerous Ideas In Drug Development
31 minutes 2 seconds
1 month ago
Precision AI with Artera

Join us this episode as we talk with Artera, a company leading in the AI space with personalised prognostic insights in cancer care. We learn about this fascinating development of AI in digital pathology which can be rolled out across demographics with predictive applications in prostate and other cancer streams.

Dangerous Ideas In Drug Development
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.